Simone McInerny

848 total citations
23 papers, 455 citations indexed

About

Simone McInerny is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Simone McInerny has authored 23 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 10 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Simone McInerny's work include BRCA gene mutations in cancer (18 papers), Genetic factors in colorectal cancer (7 papers) and DNA Repair Mechanisms (6 papers). Simone McInerny is often cited by papers focused on BRCA gene mutations in cancer (18 papers), Genetic factors in colorectal cancer (7 papers) and DNA Repair Mechanisms (6 papers). Simone McInerny collaborates with scholars based in Australia, China and Canada. Simone McInerny's co-authors include Paul A. James, Na Li, Ian Campbell, Simone M. Rowley, Lisa Devereux, Rodney J. Scott, Ella R. Thompson, Alison H. Trainer, Michelle W. Wong‐Brown and Gillian Mitchell and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Simone McInerny

21 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone McInerny Australia 13 312 218 116 99 77 23 455
Matthew Lubin United States 5 265 0.8× 263 1.2× 97 0.8× 52 0.5× 53 0.7× 8 413
Anna Newlin United States 12 210 0.7× 147 0.7× 46 0.4× 53 0.5× 50 0.6× 17 425
Erin O'Neil United States 6 248 0.8× 164 0.8× 92 0.8× 57 0.6× 69 0.9× 17 509
Moran Gal Israel 7 251 0.8× 188 0.9× 73 0.6× 61 0.6× 42 0.5× 9 439
Matthew Schwede United States 10 81 0.3× 173 0.8× 105 0.9× 128 1.3× 37 0.5× 22 398
Nicola Dikow Germany 11 219 0.7× 226 1.0× 29 0.3× 43 0.4× 34 0.4× 28 441
William A. Scaringe United States 14 169 0.5× 468 2.1× 126 1.1× 66 0.7× 19 0.2× 22 609
Helen Gregory United Kingdom 7 215 0.7× 119 0.5× 77 0.7× 48 0.5× 51 0.7× 12 335
N. Weinberg Israel 7 334 1.1× 281 1.3× 69 0.6× 41 0.4× 71 0.9× 8 512
Anna M. Jansen Netherlands 11 175 0.6× 168 0.8× 139 1.2× 81 0.8× 172 2.2× 12 565

Countries citing papers authored by Simone McInerny

Since Specialization
Citations

This map shows the geographic impact of Simone McInerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone McInerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone McInerny more than expected).

Fields of papers citing papers by Simone McInerny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone McInerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone McInerny. The network helps show where Simone McInerny may publish in the future.

Co-authorship network of co-authors of Simone McInerny

This figure shows the co-authorship network connecting the top 25 collaborators of Simone McInerny. A scholar is included among the top collaborators of Simone McInerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone McInerny. Simone McInerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pishas, Kathleen I., Simone McInerny, Simone M. Rowley, et al.. (2025). Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing. npj Genomic Medicine. 10(1). 1–1.
2.
McInerny, Simone, Lyon Mascarenhas, Tatiane Yanes, et al.. (2024). Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial. BMJ Open. 14(8). e087874–e087874. 2 indexed citations
3.
Yanes, Tatiane, Mary‐Anne Young, Amanda Willis, et al.. (2023). Development and evaluation of a novel educational program for providers on the use of polygenic risk scores. Genetics in Medicine. 25(8). 100876–100876. 4 indexed citations
4.
Li, Na, Simone McInerny, Magnus Zethoven, et al.. (2022). Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. JNCI Journal of the National Cancer Institute. 115(2). 181–189. 6 indexed citations
5.
Li, Na, Simone M. Rowley, Ella R. Thompson, et al.. (2022). Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer. npj Breast Cancer. 8(1). 10–10.
6.
Yanes, Tatiane, Bettina Meiser, Rajneesh Kaur, et al.. (2021). Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior. Genetics in Medicine. 23(12). 2316–2323. 15 indexed citations
7.
Li, Na, Ella R. Thompson, Simone McInerny, et al.. (2021). Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. npj Breast Cancer. 7(1). 76–76. 13 indexed citations
8.
Gregory, Gillian, Bettina Meiser, Rajneesh Kaur, et al.. (2021). Communicating polygenic risk scores in the familial breast cancer clinic. Patient Education and Counseling. 104(10). 2512–2521. 12 indexed citations
9.
Yanes, Tatiane, Rajneesh Kaur, Bettina Meiser, et al.. (2020). Women’s responses and understanding of polygenic breast cancer risk information. Familial Cancer. 19(4). 297–306. 15 indexed citations
10.
Zethoven, Magnus, Simone McInerny, Simone M. Rowley, et al.. (2020). Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. Nature Communications. 11(1). 1640–1640. 17 indexed citations
11.
Yanes, Tatiane, Bettina Meiser, Rajneesh Kaur, et al.. (2019). Uptake of polygenic risk information among women at increased risk of breast cancer. Clinical Genetics. 97(3). 492–501. 19 indexed citations
12.
Li, Na, Simone McInerny, Magnus Zethoven, et al.. (2019). Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer. JNCI Journal of the National Cancer Institute. 111(12). 1332–1338. 23 indexed citations
13.
Li, Na, Simone M. Rowley, Ella R. Thompson, et al.. (2018). Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs. Breast Cancer Research. 20(1). 3–3. 14 indexed citations
14.
Li, Na, Ella R. Thompson, Simone M. Rowley, et al.. (2016). Reevaluation of RINT1 as a breast cancer predisposition gene. Breast Cancer Research and Treatment. 159(2). 385–392. 12 indexed citations
15.
Thompson, Ella R., Simone M. Rowley, Na Li, et al.. (2016). Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care. Journal of Clinical Oncology. 34(13). 1455–1459. 137 indexed citations
16.
Thompson, Ella R., Kylie L. Gorringe, Simone M. Rowley, et al.. (2015). Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls. Breast Cancer Research. 17(1). 111–111. 29 indexed citations
17.
Thompson, Ella R., Kylie L. Gorringe, Simone M. Rowley, et al.. (2015). Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context. Scientific Reports. 5(1). 14800–14800. 28 indexed citations
18.
Leeuw, Charles N. de, Frank M. Dyka, Sanford L. Boye, et al.. (2014). Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors. Molecular Therapy — Methods & Clinical Development. 1. 5–5. 42 indexed citations
19.
Castellarin, Mauro, Kathleen G. Banks, Russell J. Bonaguro, et al.. (2013). Non-coding-regulatory regions of human brain genes delineated by bacterial artificial chromosome knock-in mice. BMC Biology. 11(1). 106–106. 3 indexed citations
20.
McInerny, Simone, Amanda Brown, & Doug W. Smith. (2009). Region-specific changes in mitochondrial D-loop in aged rat CNS. Mechanisms of Ageing and Development. 130(5). 343–349. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Lubin Breakdown of academic impact, for papers by Anna Newlin Breakdown of academic impact, for papers by Erin O'Neil Breakdown of academic impact, for papers by Moran Gal Breakdown of academic impact, for papers by Matthew Schwede Breakdown of academic impact, for papers by Nicola Dikow Breakdown of academic impact, for papers by William A. Scaringe Breakdown of academic impact, for papers by Helen Gregory Breakdown of academic impact, for papers by N. Weinberg Breakdown of academic impact, for papers by Anna M. Jansen
Rankless by CCL
2026